CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Vigil Neuroscience

For profit

Also known as: Vigil Neuroscience, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Sep 27, 2023

Acquired by Sanofi-Aventis on May 2, 2025

Timeline

2020s

Jan 1, 2020
Vigil Neuroscience— Founded
May 2, 2025
Sanofi-Aventis— Acquired By

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (1 own, 0 via acquisition)

vgl101

Phase 1 (1 own, 0 via acquisition)

vg-3927

Recent trials (2)

NCT06343636Lead sponsorPhase 1Sep 27, 2023
NCT05677659Lead sponsorPhase 2Dec 14, 2022

Details

Founded: Boston, MA, US Jan 1, 2020
Last known activity: Sep 27, 2023